THE DEAL, AT A GLANCE
From the announcementMammogen
01What it doesMammogen is a million to fund a clinical trial for its genTRU-breast test.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by a major UFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedMammogen raised $30M Series A, announced 2026-06-03From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersMammogen's $30M Series A is a below-median Healthcare & Life Sciences financing that still carries institutional validation because it was led by a major U.S.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Mammogen · Financing Record
Explore source-linked visual explanations for Mammogen. Unsupported claims are withheld while source review continues.
Record 5383 · Recorded date: 2026-06-03
Explore company records →